2Barnes PJ.Clinical outcome of addinglong-acting β2 -agonists to Inhaled corticosteroids[J].Resp Med,2001,(Suppl B):12.
3Hospenthal MA,Peters JI.Long-acting beta(2)-agonists in the management of asthma exacerbations[J].Curr Opin Plum Med,2005,11(1):69.
4Remington TL,Digiovine B.Long-acting beta-agonists:anti-inflammatory properties and synergy with corticosteroids in asthma[J].Curr Opin Plum Med,2005,11(1):74.
6Bjermer L,Diamant Z.Current and emerging nonsteroidal anti-inflammatory therapies targeting specific mechanisms in asthma and allergy[J].Treat Respir Med,2004,3(4):235.
7Vignola.AMPDE4 inhibitors in COPD-a more selective approach to treatment[J].Respir Med,2004,98(6):495.
8Draheim R,Egerland U,Rundfeldt C,et al.Anti inflammatory potential of the selective phosphodiesterase 4inhibitor.N-(3,5-Dichloro-pyrid-4-yl)-[1-(4 -fluorobenzyl) -5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281),in human cell preparations[J].J Pharmacol Exp Ther,2004,308(2):555.
9[No authors listed] Roflumilast:APTA 2217,B9302-107,BY217,BYK 20869[J].Drugs R D,2004,5(3):176.
10Lipworth BJ.Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease[J].Lancet,2005,365(9 454):167.
